Rivaroxaban 10,15,20 mg Caps

Rivaroxaban 10,15,20 mg Caps
Product Description

10,15,20 mg Caps

Sanovel

  • Country/Region:
    Türkiye
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

Sanovel

  • Country/Region:
    Türkiye
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Sanovel (1)